Literature DB >> 30215146

Drug-Polymer Interaction, Pharmacokinetics and Antitumor Effect of PEG-PLA/Taxane Derivative TM-2 Micelles for Intravenous Drug Delivery.

Qiao Wang1, Yi Liu1, Chenguang Pu1, Hongjuan Zhang1, Xinyi Tan1, Jingxin Gou1, Haibing He1, Tian Yin1, Yu Zhang1, Yanjiao Wang2, Xing Tang1.   

Abstract

PURPOSE: A novel polymer micelle was prepared with a high drug loading, good stability, high tolerance and better anti-tumor effect.
METHODS: TM-2 was encapsulated in poly-block-poly (D, L-lactic acid) self-assembled micelles by the thin-film hydration method. From the critical micelle concentrations of the copolymers, particle size, drug loading and encapsulation efficiency of drug-loading micelles, the appropriate polymer material could be assessed. Comparisons between TM-2 solution and TM-2 micelles were done to evaluate the pharmacokinetics and toxicity in rats, compared with Taxol to evaluate the anti-tumor effect in mice.
RESULTS: The optimized TM-2 micelles achieved a high drug loading (~20%) with the polymer material of PEG2k-PLA2.5k, with a particle size of 30 nm and no significant change in particle size after lyophilization. The result of pharmacokinetic experiment displayed that the half-life in vivo was obviously prolonged. The maximum tolerated dose of TM-2 micelles was approximately 25 mg/kg in rats, and the relative tumor growth rate of Taxol (15 mg/kg), TM-2 (10 mg/kg), TM-2 (15 mg/kg) and TM-2 (40 mg/kg) in mice were 49.35%, 49.14%, 36.44 and 9.98% respectively.
CONCLUSIONS: TM-2 micelles with high drug loading increased drug solubility, improved tolerance, antitumor effects and reduced toxicity.

Entities:  

Keywords:  anti-tumor effect; high drug loading; polymer micelles; tm-2; toxicity

Mesh:

Substances:

Year:  2018        PMID: 30215146     DOI: 10.1007/s11095-018-2477-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

Review 1.  Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: illustration with the case of taxane therapeutics.

Authors:  L Harivardhan Reddy; Didier Bazile
Journal:  Adv Drug Deliv Rev       Date:  2013-11-01       Impact factor: 15.470

2.  Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Authors:  Nuhad K Ibrahim; Neil Desai; Sewa Legha; Patrick Soon-Shiong; Richard L Theriault; Edgardo Rivera; Bita Esmaeli; Sigrid E Ring; Agop Bedikian; Gabriel N Hortobagyi; Julie A Ellerhorst
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

3.  Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles.

Authors:  Ling Xiao; Xiaoqin Xiong; Xiaohui Sun; Yanhong Zhu; Hao Yang; Huabing Chen; Lu Gan; Huibi Xu; Xiangliang Yang
Journal:  Biomaterials       Date:  2011-05-04       Impact factor: 12.479

4.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

5.  Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors.

Authors:  Kazuhiko Yamada; Noboru Yamamoto; Yasuhide Yamada; Toru Mukohara; Hironobu Minami; Tomohide Tamura
Journal:  Jpn J Clin Oncol       Date:  2010-02-04       Impact factor: 3.019

6.  Self-assembled polymeric micellar nanoparticles as nanocarriers for poorly soluble anticancer drug ethaselen.

Authors:  Xinru Li; Zhuoli Yang; Kewei Yang; Yanxia Zhou; Xingwei Chen; Yanhui Zhang; Fei Wang; Yan Liu; Lijun Ren
Journal:  Nanoscale Res Lett       Date:  2009-09-16       Impact factor: 4.703

7.  Development of a rapid and sensitive UPLC-MS/MS assay for the determination of TM-2 in beagle dog plasma and its application to a pharmacokinetic study.

Authors:  Hongli Lin; Yunli Zhao; Lei Men; Mingjing Yang; Hui Liu; Yanjie Shao; Pei Wang; Xing Tang; Zhiguo Yu
Journal:  Biomed Chromatogr       Date:  2014-05-15       Impact factor: 1.902

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.

Authors:  Daniel D Von Hoff; Monica M Mita; Ramesh K Ramanathan; Glen J Weiss; Alain C Mita; Patricia M LoRusso; Howard A Burris; Lowell L Hart; Susan C Low; Donald M Parsons; Stephen E Zale; Jason M Summa; Hagop Youssoufian; Jasgit C Sachdev
Journal:  Clin Cancer Res       Date:  2016-02-04       Impact factor: 12.531

10.  A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity.

Authors:  Zhijian He; Xiaomeng Wan; Anita Schulz; Herdis Bludau; Marina A Dobrovolskaia; Stephan T Stern; Stephanie A Montgomery; Hong Yuan; Zibo Li; Daria Alakhova; Marina Sokolsky; David B Darr; Charles M Perou; Rainer Jordan; Robert Luxenhofer; Alexander V Kabanov
Journal:  Biomaterials       Date:  2016-06-04       Impact factor: 12.479

View more
  4 in total

1.  A Comprehensive Preclinical Evaluation of Intravenous Etoposide Lipid Emulsion.

Authors:  Xiaoyu Liu; Lifeng Luo; Pan Qi; Yi Liu; Tian Yin; Jingxin Gou; Haibing He; Yu Zhang; Xing Tang
Journal:  Pharm Res       Date:  2019-05-10       Impact factor: 4.200

2.  Novel Self-Assembled Micelles With Increased Tumor Penetration and Anti-Tumor Efficiency Against Breast Cancer.

Authors:  Yani Yang; Yuezhu Zhao; Jie Liu; Chen Ge; Weiwei Zhang; Yue Zhang; Junji Wang; Guohao Sun; Xiujun Lin; Xiaohong Lu; Xiang Tang; Jun He; Weigen Lu; Jing Qin
Journal:  Pharm Res       Date:  2022-07-29       Impact factor: 4.580

3.  TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization.

Authors:  Lina Jia; Xiaoyun Gao; Yi Fang; Haotian Zhang; Lihui Wang; Xing Tang; Jingyu Yang; Chunfu Wu
Journal:  Apoptosis       Date:  2022-09-15       Impact factor: 5.561

4.  Ultrasonic Film Rehydration Synthesis of Mixed Polylactide Micelles for Enzyme-Resistant Drug Delivery Nanovehicles.

Authors:  Darya A Stepanova; Vladislava A Pigareva; Anna K Berkovich; Anastasia V Bolshakova; Vasiliy V Spiridonov; Irina D Grozdova; Andrey V Sybachin
Journal:  Polymers (Basel)       Date:  2022-09-25       Impact factor: 4.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.